enteral stents market growth, enteral stents market size, enteral stents market uk, enteral stents market trends, enteral stents market scope, enteral stents market forecast
How large is the enteral stents market, and what is its growth trajectory?
The enteral stents market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to improved endoscopic techniques, favorable reimbursement policies, higher surgical success rates, regulatory approvals, and higher awareness of GI treatments.
The enteral stents market size is expected to see strong growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to a focus on quality of life, enhanced biocompatibility research, green manufacturing, expansion of healthcare insurance, and adoption of value-based care. Major trends in the forecast period include next-generation biodegradable stents, AI-driven stent customization, bioactive stents, wireless communication-enabled stents, and CRISPR-integrated drug delivery.
Get Your Free Sample of The Global Enteral Stents Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20774&type=smp
What are the key forces behind the enteral stents market’s growth in recent years?
The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the enteral stents market going forward. Gastrointestinal disorders refer to a wide range of conditions affecting the gastrointestinal tract, including the esophagus, stomach, intestines, and accessory organs, leading to symptoms such as pain and discomfort. The increasing prevalence of gastrointestinal disorders is due to poor dietary habits, rising stress levels, sedentary lifestyles, increased use of antibiotics, and growing exposure to environmental toxins. Enteral stents are essential in managing gastrointestinal disorders by offering a minimally invasive solution to relieve obstructions, restore the natural flow of food and fluids, and improve overall digestive function, thereby enhancing patient comfort and quality of life. For instance, in June 2023, according to Crohn’s and Colitis Canada, a Canada-based nonprofit organization, in 2023, an estimated 322,600 Canadians, accounting for 0.8% of the population, were living with IBD. Projections indicate this figure could rise to 470,000, or 1.1% of the population, by 2035. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the enteral stent market.
Rising Cancer Prevalence Driving Market Growth
The rising prevalence of cancer is expected to propel the growth of the enteral stents market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is driven by an aging population, lifestyle factors, improved diagnostic methods, genetic predisposition, and better healthcare access and awareness. Enteral stents are used to relieve gastrointestinal obstructions caused by cancer, improving symptoms such as dysphagia and preserving nutrient intake. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases are projected, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the enteral stents market.
What are the major segments of the enteral stents market?
The enteral stents market covered in this report is segmented –
1) By Stent Type: Esophageal Stents, Gastroduodenal Stents, Colon Stents
2) By Material Type: Self-Expandable Plastic Stents, Self-Expandable Metal Stents
3) By End User: Hospitals, Specialty Clinics, Ambulatory Centers, Research Centers
Subsegments:
1) By Esophageal Stents: Self-Expanding Metal Esophageal Stents, Covered Esophageal Stents, Uncovered Esophageal Stents, Hybrid Esophageal Stents, Temporary Esophageal Stents
2) By Gastroduodenal Stents: Self-Expanding Metal Gastroduodenal Stents, Covered Gastroduodenal Stents, Uncovered Gastroduodenal Stents, Biodegradable Gastroduodenal Stents
3) By Colon Stents: Self-Expanding Metal Colon Stents, Covered Colon Stents, Uncovered Colon Stents, Biodegradable Colon Stents, Colon Stents For Colonic Obstruction
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/enteral-stents-global-market-report
Which companies dominate the enteral stents market?
Major companies operating in the enteral stents market are Cardinal Health Inc., Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, AMETEK Inc., Lepu Medical Technology (Beijing) Co Ltd., Endo-Therapeutics Inc., Cook Medical, Micro-Tech (Nanjing) Co Ltd., Merit Medical Systems Inc., ConMed Corporation, GBUK Group Ltd., Biosensors International Group Ltd., Medi-Globe GmbH, BVM Medical Limited, Taewoong Medical Inc., ELLA-CS s.r.o., Mitra Industries Inc., Hobbs Medical Inc.
What are the key regional dynamics of the enteral stents market, and which region leads in market share?
North America was the largest region in the enteral stents market in 2024. The regions covered in the enteral stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Enteral Stents Market Report 2025 Offer?
The enteral stents market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Enteral stents are medical devices inserted into the digestive tract to relieve blockages or narrowing, typically caused by tumors or other gastrointestinal issues. These stents help maintain an open passage for food or waste, providing temporary or long-term relief for patients with conditions such as cancer or crohn’s disease.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20774
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
